Pixium Vision Investors

16 investors on Angel Roster list Pixium Vision in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in France, the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Pixium Vision can appear together.

Investors listed
16
With verified email
31%
Most common stage
Series B
Top location
France

Updated October 13, 2026 · How we compile this data

Top 16 Pixium Vision investors

The most complete profiles first. Showing 16 of 16.

  • Antoine PapiernikVerified

    Venture Capital, Private Equity Firm, Investor · France

    SeedInvestment ManagementBiotechnologyClean TechnologyFinTech

    Portfolio: Home Biosciences, Shockwave Medical, TISSIUM, Lectus Therapeutics and 9 more

    Verified email available

  • Ken HaasVerified

    Venture Capital, Advisor, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • andrew sinclairVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Shelley ChuVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Tim HainesVerified

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Bali Muralidhar

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more

    Contact details available

  • Brian Gallagher, Jr.

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more

    Contact details available

  • Kurt von Emster

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedInvestment ManagementLife Science

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Vin Miles

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Avi Corcos

    Venture Capital · France

    Health CareE-commerceCybersecurityHR Tech

    Portfolio: VSORA, eFrontech, viavoo, Tiller Systems and 76 more

    Contact details available

  • John Heard

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Marc

    Venture Capital · France

    Health CareE-commerceCybersecurityHR Tech

    Portfolio: VSORA, eFrontech, viavoo, Tiller Systems and 76 more

    Contact details available

  • Renaud POULARD

    Venture Capital, Private Equity Firm · France

    Health CareE-commerceCybersecurityDeepTech

    Portfolio: VSORA, eFrontech, viavoo, Tiller Systems and 76 more

    Contact details available

  • Sarah Shackelton

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Serge Savasta

    Venture Capital, Private Equity Firm · France

    Health CareE-commerceCybersecurityDeepTech

    Portfolio: VSORA, eFrontech, viavoo, Tiller Systems and 76 more

    Contact details available

  • Yoann Malys

    Venture Capital · France

    Health CareE-commerceCybersecurityHR Tech

    Portfolio: VSORA, eFrontech, viavoo, Tiller Systems and 76 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Pixium Vision investors are on Angel Roster?

Angel Roster lists 16 Pixium Vision investors. 5 of them (31%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Private Equity Firms (7) and Advisor Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Pixium Vision investors invest in?

Among those that list a stage, the most common are Series B (6) and Seed (1).

Where are Pixium Vision investors based?

Most are based in France (6), the United States (5) and the United Kingdom (5).

Which companies have Pixium Vision investors backed?

The most-backed portfolio companies among them are Fovea Pharmaceuticals (11), Paratek Pharmaceuticals (10), Phathom Pharmaceuticals (10), Stanmore Implants Worldwide (10) and IS Pharma (10).

How do I contact Pixium Vision investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.